Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-08-16 4:30 pm Purchase |
2023-08-15 | 13G | Delcath Systems, Inc. DCTH |
Soleus Capital Master Fund, L.P. | 806,420 5.300% |
806,420![]() (New Position) |
Filing History |
2023-08-11 4:31 pm Purchase |
2023-08-08 | 13G | AxoGen, Inc. AXGN |
Soleus Capital Master Fund, L.P. | 3,541,298 8.200% |
3,541,298![]() (New Position) |
Filing History |
2023-07-27 4:30 pm Purchase |
2023-07-26 | 13G | Verastem, Inc. VSTM |
Soleus Capital Master Fund, L.P. | 1,297,369 5.100% |
1,297,369![]() (New Position) |
Filing History |
2023-04-14 5:07 pm Purchase |
2023-04-13 | 13G | C4 Therapeutics, Inc. CCCC |
Soleus Capital Master Fund, L.P. | 2,462,020 5.000% |
2,462,020![]() (New Position) |
Filing History |
2023-02-22 4:03 pm Purchase |
2023-02-21 | 13G | Rigel Pharmaceuticals, Inc. RIGL |
Soleus Capital Master Fund, L.P. | 922,302 5.300% |
922,302![]() (New Position) |
Filing History |
2023-02-14 08:22 am Purchase |
2022-12-31 | 13G | Organogenesis Holdings Inc. ORGO |
Soleus Capital Master Fund, L.P. | 7,363,063 5.600% |
737,000![]() (+11.12%) |
Filing History |
2023-02-14 08:19 am Purchase |
2022-12-31 | 13G | EDAP TMS S.A. EDAP |
Soleus Capital Master Fund, L.P. | 5,134,430 14.000% |
244,685![]() (+5.00%) |
Filing History |
2023-02-14 08:16 am Purchase |
2022-12-31 | 13G | IRadimed Corporation IRMD |
Soleus Capital Master Fund, L.P. | 745,004 5.900% |
98,593![]() (+15.25%) |
Filing History |
2023-02-14 08:16 am Purchase |
2022-12-31 | 13G | Surmodics, Inc. SRDX |
Soleus Capital Master Fund, L.P. | 775,311 5.500% |
61,347![]() (+8.59%) |
Filing History |
2023-02-14 08:14 am Purchase |
2022-12-31 | 13G | Theratechnologies Inc. THTX |
Soleus Capital Master Fund, L.P. | 2,587,281 10.700% |
168,304![]() (+6.96%) |
Filing History |
2023-02-14 08:14 am Sale |
2022-12-31 | 13G | Apollo Endosurgery, Inc. APEN |
Soleus Capital Master Fund, L.P. | 0 0.000% |
-2,295,100![]() (Position Closed) |
Filing History |
2023-02-14 08:09 am Sale |
2022-12-31 | 13G | CVRx, Inc. CVRX |
Soleus Capital Master Fund, L.P. | 1,014,640 4.900% |
-29,400![]() (-2.82%) |
Filing History |
2023-02-14 08:06 am Sale |
2022-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
Soleus Capital Master Fund, L.P. | 0 0.000% |
-498,279![]() (Position Closed) |
Filing History |
2023-02-14 08:00 am Purchase |
2022-12-31 | 13G | Celcuity Inc. CELC |
Soleus Capital Master Fund, L.P. | 2,285,554 9.900% |
1,337,165![]() (+140.99%) |
Filing History |
2023-01-30 5:01 pm Purchase |
2023-01-27 | 13G | Jasper Therapeutics, Inc. JSPR |
Soleus Capital Master Fund, L.P. | 625,000 5.700% |
625,000![]() (New Position) |
Filing History |
2023-01-27 5:02 pm Purchase |
2023-01-25 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Soleus Capital Master Fund, L.P. | 50,000 5.400% |
37,500![]() (+300.00%) |
Filing History |
2023-01-26 5:01 pm Sale |
2022-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Soleus Capital Master Fund, L.P. | 12,500 1.300% |
-36,061![]() (-74.26%) |
Filing History |
2022-11-14 5:00 pm Purchase |
2022-11-11 | 13G | Theratechnologies Inc. THTX |
Soleus Capital Master Fund, L.P. | 2,418,977 10.010% |
108,457![]() (+4.69%) |
Filing History |
2022-10-13 5:01 pm Purchase |
2022-10-11 | 13G | Organogenesis Holdings Inc. ORGO |
Soleus Capital Master Fund, L.P. | 6,626,063 5.100% |
6,626,063![]() (New Position) |
Filing History |
2022-09-28 5:01 pm Purchase |
2022-09-27 | 13G | EDAP TMS S.A. EDAP |
Soleus Capital Master Fund, L.P. | 4,889,745 13.400% |
1,741,136![]() (+55.30%) |
Filing History |